Immutep Limited (IMM.AX) — Stock Score Summary

Immutep Limited (IMM.AX) has a MoatMap StockRank of 8/100 based on Quality (31/100), Value (41/100), and Momentum (18/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price$0.04
Market Cap$58M
P/E (Forward)-1.88
Price/Book0.88
Return on Equity-61.8%
Return on Invested Capital-22.3%
Debt/Equity1.22
Gross Margin0.0%
Operating Margin-763.7%
Revenue Growth91.5%
Free Cash Flow$-16M

Immutep Limited operates in the Biotechnology industry, part of the Healthcare sector (Australia).

Frequently Asked Questions

What is Immutep Limited’s (IMM.AX) StockRank?
MoatMap’s StockRank for Immutep Limited (IMM.AX) is 8/100, with a Strong Sell signal. It is a composite of Quality (31), Value (41), and Momentum (18) factor ranks across MoatMap’s 15,000+ stock universe.
Does Immutep Limited have an economic moat?
Immutep Limited (IMM.AX) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Immutep Limited a buy, hold, or sell?
MoatMap’s current signal for Immutep Limited (IMM.AX) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Immutep Limited in?
Immutep Limited (IMM.AX) operates in the Healthcare sector, specifically the Biotechnology industry (Australia).
Browse all ranked stocksIMM.AX deep dive reportAI ChampionsHow we score stocksSense-check another stock